FIORE, WALTER
FIORE, WALTER
Dipartimento di Scienze per gli Alimenti, la Nutrizione e l'Ambiente
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome
2024 G. Gargari, G. Mantegazza, C. Cremon, V. Taverniti, A. Valenza, M. Barbaro, G. Marasco, R. Duncan, W. Fiore, R. Ferrari, V. De Vitis, G. Barbara, S. Guglielmetti
Co-administration of vitamin D3 and Lacticaseibacillus paracasei DG increase 25-hydroxyvitamin D serum levels in mice
2021 I. Castagliuolo, M. Scarpa, P. Brun, G. Bernabe, V. Sagheddu, M. Elli, W. Fiore, V. De Vitis, S. Guglielmetti
OVERALL ASSESSMENT OF A MODEL PROBIOTIC BACTERIUM: FROM GUT COLONIZATION TO CLINICAL EFFICACY
2020 W. Fiore
Effect of oral consumption of capsules containing Lactobacillus paracasei LPC-S01 on the vaginal microbiota of healthy adult women: a randomized, placebo-controlled, double-blind crossover study
2020 R. Koirala, G. Gargari, S. Arioli, V. Taverniti, W. Fiore, E. Grossi, G.M. Anelli, I. Cetin, S. Guglielmetti
The neglected microbial components of commercial probiotic formulations
2020 W. Fiore, S. Arioli, S. Guglielmetti
Survival of L. casei DG((R)) (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population
2019 M. Radicioni, R. Koirala, W. Fiore, C. Leuratti, S. Guglielmetti, S. Arioli
Quantitative recovery of viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) after gastrointestinal passage in healthy adults
2018 S. Arioli, R. Koirala, V. Taverniti, W. Fiore, S. Guglielmetti
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome
2018 G. Gargari, V. Taverniti, C. Gardana, C. Cremon, F. Canducci, I. Pagano, M.R. Barbaro, L. Bellacosa, A.M. Castellazzi, C. Valsecchi, S.C. Tagliacarne, M. Bellini, L. Bertani, D. Gambaccini, S. Marchi, M. Cicala, B. Germanà, E. Dal Pont, M. Vecchi, C.M. Ogliari, W. Fiore, V. Stanghellini, G. Barbara, S. Guglielmetti
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome : a pilot randomized clinical trial
2018 C. Cremon, S. Guglielmetti, G. Gargari, V. Taverniti, A.M. Castellazzi, C. Valsecchi, C. Tagliacarne, W. Fiore, M. Bellini, L. Bertani, D. Gambaccini, M. Cicala, B. Germanà, M. Vecchi, I. Pagano, M.R. Barbaro, L. Bellacosa, V. Stanghellini, G. Barbara
A novel rhamnose-rich hetero-exopolysaccharide isolated from Lactobacillus paracasei DG activates THP-1 human monocytic cells
2017 S. Balzaretti, V. Taverniti, S. Guglielmetti, W. Fiore, M. Minuzzo, H.N. Ngo, J.B. Ngere, S. Sadiq, P.N. Humphreys, A.P. Laws
The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration
2015 S. Balzaretti, V. Taverniti, G. Rondini, G. Marcolegio, M. Minuzzo, M.C. Remagni, W. Fiore, S. Arioli, S. Guglielmetti
Modulation of Fecal Clostridiales Bacteria and Butyrate by Probiotic Intervention with Lactobacillus paracasei DG Varies among Healthy Adults
2014 C. Ferrario, V. Taverniti, C. Milani, W. Fiore, M. Laureati, I. De Noni, M. Stuknyte, B. Chouaia, P. Riso, S. Guglielmetti